Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

3,297 results
MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1971 1
1973 2
1974 4
1975 19
1976 23
1977 76
1978 113
1979 114
1980 114
1981 105
1982 97
1983 92
1984 58
1985 78
1986 62
1987 67
1988 66
1989 56
1990 48
1991 61
1992 45
1993 48
1994 33
1995 49
1996 42
1997 50
1998 43
1999 49
2000 60
2001 47
2002 56
2003 68
2004 50
2005 59
2006 84
2007 99
2008 93
2009 90
2010 113
2011 139
2012 141
2013 153
2014 140
2015 147
2016 127
2017 115
2018 116
2019 33
Text availability
Article attribute
Article type
Publication date

Search Results

3,297 results
Results by year
Filters applied: . Clear all
Page 1
Continuation of copper and levonorgestrel intrauterine devices: a retrospective cohort study.
Phillips SJ, et al. Am J Obstet Gynecol 2017. PMID 28315664 Free PMC article.
BACKGROUND: Studies conflict on whether the duration of use of the copper intrauterine device is longer than that of the levonorgestrel intrauterine device, and whether women who continue using intrauterine devices differ from those who discontinue. OBJECTIVE: We sought to assess continuation rates and performance of levonorgestrel intrauterine devices compared with copper intrauterine devices over a 5-year period. ...
BACKGROUND: Studies conflict on whether the duration of use of the copper intrauterine device is longer than that of the levonorgestrel intrauterine device, and whether women who continue using intrauterine devices differ from those who discontinue. OBJECTIVE: We sought t …
Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices.
Heinemann K, et al. Contraception 2015 - Clinical Trial. PMID 25601352 Free article.
OBJECTIVES: The objectives were to identify and compare the incidence of uterine perforation and other medically adverse events associated with levonorgestrel-releasing intrauterine systems (LNG-IUSs, releasing 20 mcg LNG daily) and copper intrauterine devices (IUDs) under routine conditions of use in a study population representative of typical users. ...IMPLICATIONS: The European Active Surveillance Study on Intrauterine Devices is the first large-scale, prospective, non-interventional study to compare the perforation risk in LNG-IUS and copper IUD users. ...
OBJECTIVES: The objectives were to identify and compare the incidence of uterine perforation and other medically adverse events associated with levonorgestrel-releasing intrauterine systems (LNG-IUSs, releasing 20 mcg LNG daily) and copper intrauterine devices (IUDs) under routi …
Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review.
Sanders JN, et al. Am J Obstet Gynecol 2017. PMID 28188772 Free PMC article.
RESULTS: Data on 8603 device insertions were obtained with the following distribution: levonorgestrel 52-mg intrauterine devices (6459; 75.1%), copper T380A intrauterine devices (1136; 13.2%), and 68-mg etonogestrel implant (1008; 11.7%). ...CONCLUSION: Three-quarters of women with an intrauterine device or implant continue using it for 2 years. In this cohort, the 2-year continuation rates were 77.8%, 73.1%, and 75.9% for the levonorgestrel 52-mg intrauterine device, copper T380A intrauterine device, and 68-mg etonogestrel implant, respectively....
RESULTS: Data on 8603 device insertions were obtained with the following distribution: levonorgestrel 52-mg intrauterine devices (6459; 75.1%), copper T380A intrauterine devices (1136; 13.2%), and 68-mg etonogestrel implant (1008; 11.7%). ...CONCLUSION: Three-quarters of …
Extended use of the intrauterine device: a literature review and recommendations for clinical practice.
Wu JP and Pickle S. Contraception 2014 - Review. PMID 24679478
There are multiple advantages to "extended use" of the intrauterine device (IUD) use beyond the manufacturer-approved time period, including prolongation of contraceptive and non-contraceptive benefits. ...Among parous women who are at least 25 years old at the time of IUD insertion, there is good evidence to support extended use of the following devices: the TCu380A and the TCu220 for 12 years, the Multiload Cu-375 for 10 years, the frameless GyneFix® (330 mm²) for 9 years, the levonorgestrel intrauterine system 52 mg (Mirena®) for 7 years and the Multiload Cu-250 for 4 years. ...
There are multiple advantages to "extended use" of the intrauterine device (IUD) use beyond the manufacturer-approved time period, including prolongation of contraceptive and non-contraceptive benefits. ...Among parous women who are at least 25 years old at the time of IUD insertion, there is …
Intrauterine devices and adolescents.
Gold MA and Johnson LM. Curr Opin Obstet Gynecol 2008 - Review. PMID 18797269
PURPOSE OF REVIEW: The purpose of this review is to inform the reader of new information published on intrauterine devices (IUDs) and adolescents. ...The levonorgestrel-releasing intrauterine system (LNG IUS) is a particularly good choice for adolescents because of associated noncontraceptive benefits such as decreased menstrual bleeding, dysmenorrhea and pain associated with endometriosis. ...
PURPOSE OF REVIEW: The purpose of this review is to inform the reader of new information published on intrauterine devices (IUDs) and adolescents. ...The levonorgestrel-releasing intrauterine system (LNG IUS) is a particularly good choice for adolescents because of associated no …
Bleeding pattern difference between levonorgestrel intrauterine system and copper intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women.
Chen X, et al. Curr Med Res Opin 2018 - Clinical Trial. PMID 29298525
BACKGROUND: To describe the bleeding pattern (primary outcome), side effects, treatment satisfaction and 6 month continuity rates associated with the 52 mg levonorgestrel intrauterine system (LNG-IUS) and the copper intrauterine device (Cu-IUD) inserted immediately after abortion. ...
BACKGROUND: To describe the bleeding pattern (primary outcome), side effects, treatment satisfaction and 6 month continuity rates associated with the 52 mg levonorgestrel intrauterine system (LNG-IUS) and the copper intrauterine device (Cu-IUD) inserted immediately after abortion. ...
Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis.
Eggebroten JL, et al. Am J Obstet Gynecol 2017. PMID 28342716
BACKGROUND: In-hospital placement of intrauterine devices and contraceptive implants following vaginal and cesarean delivery is increasingly popular and responds to maternal motivation for highly effective postpartum contraception. ...OBJECTIVE: This study evaluated in-hospital provision, expulsion, and 6-month continuation of immediate postpartum copper T380 intrauterine devices, levonorgestrel intrauterine devices, and contraceptive implants. ...
BACKGROUND: In-hospital placement of intrauterine devices and contraceptive implants following vaginal and cesarean delivery is increasingly popular and responds to maternal motivation for highly effective postpartum contraception. ...OBJECTIVE: This study evaluated in-hospital provisi …
3,297 results
Jump to page
Feedback